These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21711072)

  • 1. Effect of the pay-for-performance program for breast cancer care in Taiwan.
    Kuo RN; Chung KP; Lai MS
    Am J Manag Care; 2011 May; 17(5 Spec No):e203-11. PubMed ID: 21711072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the Pay-for-Performance Program for Breast Cancer Care in Taiwan.
    Kuo RN; Chung KP; Lai MS
    J Oncol Pract; 2011 May; 7(3 Suppl):e8s-e15s. PubMed ID: 21886513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a PPO pay-for-performance program on patients with diabetes.
    Chen JY; Tian H; Taira Juarez D; Hodges KA; Brand JC; Chung RS; Legorreta AP
    Am J Manag Care; 2010 Jan; 16(1):e11-9. PubMed ID: 20059287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pay-for-performance program for diabetes care in Taiwan: a preliminary assessment.
    Lee TT; Cheng SH; Chen CC; Lai MS
    Am J Manag Care; 2010 Jan; 16(1):65-9. PubMed ID: 20148607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the relationship between a chronic disease care management program and california pay-for-performance diabetes care cholesterol measures in one medical group.
    Cutler TW; Palmieri J; Khalsa M; Stebbins M
    J Manag Care Pharm; 2007 Sep; 13(7):578-88. PubMed ID: 17874864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of pay-for-performance on tuberculosis treatment in Taiwan.
    Li YH; Tsai WC; Khan M; Yang WT; Lee TF; Wu YC; Kung PT
    Health Policy Plan; 2010 Jul; 25(4):334-41. PubMed ID: 20207703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient assessment of diabetes care in a pay-for-performance program.
    Chiu HC; Hsieh HM; Lin YC; Kuo SJ; Kao HY; Yeh SC; Chang WH; Hsiao PJ; Chen YS; Lin SL; Lo GH; Ker CG; Hung YH; Cheng HA; Chou TH; Chou SY; Wang JH; Wang CF
    Int J Qual Health Care; 2016 Apr; 28(2):183-90. PubMed ID: 26819445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The response of physician groups to P4P incentives.
    Mehrotra A; Pearson SD; Coltin KL; Kleinman KP; Singer JA; Rabson B; Schneider EC
    Am J Manag Care; 2007 May; 13(5):249-55. PubMed ID: 17488190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using financial incentives to improve the care of tuberculosis patients.
    Lee CY; Chi MJ; Yang SL; Lo HY; Cheng SH
    Am J Manag Care; 2015 Jan; 21(1):e35-42. PubMed ID: 25880266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The early experience of a hospital-based pay-for-performance program.
    Sautter KM; Bokhour BG; White B; Young GJ; Burgess JF; Berlowitz D; Wheeler JR
    J Healthc Manag; 2007; 52(2):95-107; discussion 107-8. PubMed ID: 17447537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovative health reform models: pay-for-performance initiatives.
    Glickman SW; Peterson ED
    Am J Manag Care; 2009 Dec; 15(10 Suppl):S300-5. PubMed ID: 20088634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pay for performance schemes in primary care: what have we learnt?
    Peckham S; Wallace A
    Qual Prim Care; 2010; 18(2):111-6. PubMed ID: 20529472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does pay for performance improve cardiovascular care in a "real-world" setting?
    Chen JY; Tian H; Juarez DT; Yermilov I; Braithwaite RS; Hodges KA; Legorreta A; Chung RS
    Am J Med Qual; 2011; 26(5):340-8. PubMed ID: 21487050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pay-for-performance in safety net settings: issues, opportunities, and challenges for the future.
    Young G; Meterko M; White B; Sautter K; Bokhour B; Baker E; Silver J
    J Healthc Manag; 2010; 55(2):132-41; discussion 141-2. PubMed ID: 20402368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors related to continuing care and interruption of P4P program participation in patients with diabetes.
    Yen SM; Kung PT; Sheen YJ; Chiu LT; Xu XC; Tsai WC
    Am J Manag Care; 2016 Jan; 22(1):e18-30. PubMed ID: 26799201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pay-for-performance program in Taiwan improved care for some diabetes patients, but doctors may have excluded sicker ones.
    Chang RE; Lin SP; Aron DC
    Health Aff (Millwood); 2012 Jan; 31(1):93-102. PubMed ID: 22232099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicians respond to pay-for-performance incentives: larger incentives yield greater participation.
    de Brantes FS; D'Andrea BG
    Am J Manag Care; 2009 May; 15(5):305-10. PubMed ID: 19435398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to quality indicators and survival in patients with breast cancer.
    Cheng SH; Wang CJ; Lin JL; Horng CF; Lu MC; Asch SM; Hilborne LH; Liu MC; Chen CM; Huang AT
    Med Care; 2009 Feb; 47(2):217-25. PubMed ID: 19169123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Nationwide COPD Pay-for-Performance Program on COPD Exacerbations in Taiwan.
    Cheng SL; Li YR; Huang N; Yu CJ; Wang HC; Lin MC; Chiu KC; Hsu WH; Chen CZ; Sheu CC; Perng DW; Lin SH; Yang TM; Lin CB; Kor CT; Lin CH
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2869-2881. PubMed ID: 34703221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a pay-for-performance program on low performing physicians.
    Chen JY; Kang N; Juarez DT; Hodges KA; Chung RS; Legorreta AP
    J Healthc Qual; 2010; 32(1):13-21; quiz 21-2. PubMed ID: 20151587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.